268 related articles for article (PubMed ID: 30373278)
1. Improving the Breadth of the Host's Immune Response to Lassa Virus.
Zapata JC; Medina-Moreno S; Guzmán-Cardozo C; Salvato MS
Pathogens; 2018 Oct; 7(4):. PubMed ID: 30373278
[TBL] [Abstract][Full Text] [Related]
2. Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development.
Ibukun FI
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244402
[TBL] [Abstract][Full Text] [Related]
3. Current research for a vaccine against Lassa hemorrhagic fever virus.
Warner BM; Safronetz D; Stein DR
Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
[TBL] [Abstract][Full Text] [Related]
4. Identification of Common CD8
Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
[TBL] [Abstract][Full Text] [Related]
5. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus.
Cross RW; Heinrich ML; Fenton KA; Borisevich V; Agans KN; Prasad AN; Woolsey C; Deer DJ; Dobias NS; Rowland MM; Lathigra R; Borrega R; Geisbert JB; Garry RF; Branco LM; Geisbert TW
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2304876120. PubMed ID: 37590417
[TBL] [Abstract][Full Text] [Related]
6. Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1
Johnson DM; Jokinen JD; Lukashevich IS
Pathogens; 2019 Jan; 8(1):. PubMed ID: 30650607
[TBL] [Abstract][Full Text] [Related]
7. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
[TBL] [Abstract][Full Text] [Related]
8. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
Heinrich ML; Boisen ML; Nelson DKS; Bush DJ; Cross RW; Koval AP; Hoffmann AR; Beddingfield BJ; Hastie KM; Rowland MM; Aimukanova I; Koval S; Lathigra R; Borisevich V; Momoh M; Sandi JD; Goba A; Odia L; Baimba F; Aiyepada JO; Ebo B; Eromon P; Ugwu C; Folarin O; Olumade T; Onyechi MN; Etafo J; Adeyemi R; Ella EE; Aminu M; Gomerep SS; Eke MA; Ogunsanya O; Akpede GO; Asogun DO; Okogbenin SA; Okokhere PO; Holst J; Shaffer JG; Schieffelin JS; Geisbert TW; Saphire EO; Happi CT; Grant DS; Garry RF; Branco LM
Sci Rep; 2020 Sep; 10(1):16030. PubMed ID: 32994446
[TBL] [Abstract][Full Text] [Related]
9. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical development of a vaccine against Lassa fever.
Banadyga L; Stein DR; Qiu X; Safronetz D
Can Commun Dis Rep; 2018 Jun; 44(6):139-147. PubMed ID: 31015807
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.
Müller H; Fehling SK; Dorna J; Urbanowicz RA; Oestereich L; Krebs Y; Kolesnikova L; Schauflinger M; Krähling V; Magassouba N; Fichet-Calvet E; Ball JK; Kaufmann A; Bauer S; Becker S; von Messling V; Strecker T
NPJ Vaccines; 2020; 5(1):71. PubMed ID: 32802410
[No Abstract] [Full Text] [Related]
12. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.
Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186
[TBL] [Abstract][Full Text] [Related]
13. Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies.
Enriquez AS; Buck TK; Li H; Norris MJ; Moon-Walker A; Zandonatti MA; Harkins SS; Robinson JE; Branco LM; Garry RF; Saphire EO; Hastie KM
Cell Rep; 2022 May; 39(8):110841. PubMed ID: 35613585
[TBL] [Abstract][Full Text] [Related]
14. Lassa virus diversity and feasibility for universal prophylactic vaccine.
Lukashevich IS; Paessler S; de la Torre JC
F1000Res; 2019; 8():. PubMed ID: 30774934
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques.
Jiang J; Banglore P; Cashman KA; Schmaljohn CS; Schultheis K; Pugh H; Nguyen J; Humeau LM; Broderick KE; Ramos SJ
Hum Vaccin Immunother; 2019; 15(9):2066-2074. PubMed ID: 31071008
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing Antibodies against Lassa Virus Lineage I.
Buck TK; Enriquez AS; Schendel SL; Zandonatti MA; Harkins SS; Li H; Moon-Walker A; Robinson JE; Branco LM; Garry RF; Saphire EO; Hastie KM
mBio; 2022 Aug; 13(4):e0127822. PubMed ID: 35730904
[TBL] [Abstract][Full Text] [Related]
17. Vaccine platforms to control Lassa fever.
Lukashevich IS; Pushko P
Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S
Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999
[TBL] [Abstract][Full Text] [Related]
19. Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.
Hastie KM; Cross RW; Harkins SS; Zandonatti MA; Koval AP; Heinrich ML; Rowland MM; Robinson JE; Geisbert TW; Garry RF; Branco LM; Saphire EO
Cell; 2019 Aug; 178(4):1004-1015.e14. PubMed ID: 31398326
[TBL] [Abstract][Full Text] [Related]
20. Antibody therapy for Lassa fever.
Cross RW; Hastie KM; Mire CE; Robinson JE; Geisbert TW; Branco LM; Ollmann Saphire E; Garry RF
Curr Opin Virol; 2019 Aug; 37():97-104. PubMed ID: 31401518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
